These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11758077)

  • 1. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin.
    Ward PB; Johnson PD; Grabsch EA; Mayall BC; Grayson ML
    Med J Aust; 2001 Nov; 175(9):480-3. PubMed ID: 11758077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.
    Song JH; Hiramatsu K; Suh JY; Ko KS; Ito T; Kapi M; Kiem S; Kim YS; Oh WS; Peck KR; Lee NY;
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4926-8. PubMed ID: 15561884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical prognosis of heteroresistant vancomycin-intermediate Staphylococcus aureus in a tertiary care center in China.
    Wang Y; Hu YJ; Ai XM; Xu HT; Sun TY
    Chin Med J (Engl); 2013 Feb; 126(3):505-9. PubMed ID: 23422115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of methicillin-resistant Staphylococcus aureus belonging to the Brazilian epidemic clone in a general hospital and emergence of heterogenous resistance to glycopeptide antibiotics among these isolates.
    dos Santos Soares MJ; da Silva-Carvalho MC; Ferreira-Carvalho BT; Figueiredo AM
    J Hosp Infect; 2000 Apr; 44(4):301-8. PubMed ID: 10877623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics and virulence factors in methicillin-susceptible, resistant, and heterogeneous vancomycin-intermediate Staphylococcus aureus from central-southern China.
    Liu C; Chen ZJ; Sun Z; Feng X; Zou M; Cao W; Wang S; Zeng J; Wang Y; Sun M
    J Microbiol Immunol Infect; 2015 Oct; 48(5):490-6. PubMed ID: 24767415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
    Ozmen Capin BB; Tekeli A; Karahan ZC
    Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical, epidemiological, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Palavecino E
    Methods Mol Biol; 2007; 391():1-19. PubMed ID: 18025665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period.
    Pantazatou A; Papaparaskevas J; Stefanou I; Papanicolas J; Demertzi E; Avlamis A
    Int J Antimicrob Agents; 2003 Jun; 21(6):542-6. PubMed ID: 12791467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus infection.
    Bradley SF
    Clin Geriatr Med; 1992 Nov; 8(4):853-68. PubMed ID: 1423139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.
    Hu HC; Kao KC; Chiu LC; Chang CH; Hung CY; Li LF; Liu TP; Lin LC; Chen NH; Huang CC; Yang CT; Lu JJ
    BMC Infect Dis; 2015 Oct; 15():444. PubMed ID: 26497595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.